Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 3 | |
Outperform | 2 | |
Hold | 6 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 10 analysts offering 12 month price targets for Zentalis Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 20.00 and a low estimate of 4.00. The median estimate represents a 115.63% increase from the last price of 3.71.
High | 439.1% | 20.00 |
Med | 115.6% | 8.00 |
Low | 7.8% | 4.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 01, 2025.
Average growth rate | -17.72% |
Average growth rate | -3.00% |
More ▼
Revenue history & estimates in USD
Average growth rate | -50.00% |
Average growth rate | 0.00% |
More ▼